| Authors: |
Bailey DL; Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia; dale.bailey@sydney.edu.au., Dickson JC; Institute of Nuclear Medicine, University College London Hospitals Foundation Trust, London, United Kingdom., Lapi SE; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama., Uribe C; Molecular Imaging and Therapy, BC Cancer, Vancouver, British Columbia, Canada., Vargas CS; Dosimetry Research for Targeted Radionuclide Therapy, Belgian Nuclear Research Centre, Mol, Belgium., Jackson P; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., Stokke C; Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway., Brosch-Lenz J; Institute of Nuclear Medicine, Bethesda, Maryland., Lang A; Foundation for the National Institutes of Health, Bethesda, Maryland; and., Graves SA; Department of Radiology, University of Iowa, Iowa City, Iowa., Sunderland JJ; Department of Radiology, University of Iowa, Iowa City, Iowa. |
